Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Current Assets (2022 - 2025)

Coya Therapeutics' Current Assets history spans 4 years, with the latest figure at $32.0 million for Q3 2025.

  • For Q3 2025, Current Assets fell 9.81% year-over-year to $32.0 million; the TTM value through Sep 2025 reached $32.0 million, down 9.81%, while the annual FY2024 figure was $44.3 million, 7.55% up from the prior year.
  • Current Assets for Q3 2025 was $32.0 million at Coya Therapeutics, down from $33.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $44.3 million in Q4 2024 and bottomed at $7.2 million in Q4 2022.
  • The 4-year median for Current Assets is $34.5 million (2024), against an average of $29.4 million.
  • The largest annual shift saw Current Assets soared 473.37% in 2023 before it fell 16.19% in 2025.
  • A 4-year view of Current Assets shows it stood at $7.2 million in 2022, then skyrocketed by 473.37% to $41.2 million in 2023, then rose by 7.55% to $44.3 million in 2024, then decreased by 27.72% to $32.0 million in 2025.
  • Per Business Quant, the three most recent readings for COYA's Current Assets are $32.0 million (Q3 2025), $33.4 million (Q2 2025), and $38.4 million (Q1 2025).